• Explore /
  • Poster
  • / Survival outcomes and toxicity in older adults with metastatic castration-resistant prostate cancer (mCRPC) treated with androgen receptor targeted (ART) therapies.

Survival outcomes and toxicity in older adults with metastatic castration-resistant prostate cancer (mCRPC) treated with androgen receptor targeted (ART) therapies.

Abstract Poster

Authors

George Mellgard

George Slade Mellgard

Icahn School of Medicine at Mount Sinai, New York, NY

George Slade Mellgard , Zakaria Chakrani , Stephen Mccroskery , Nathaniel Saffran , Nicole Taylor , Bobby Chi-Hung Liaw , Matt D. Galsky , William K. Oh , Kai Tsao , Vaibhav G. Patel

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Prostate Cancer and Urothelial Carcinoma

Track

Urothelial Carcinoma,Prostate Cancer - Advanced

Sub Track

Quality of Care/Quality Improvement and Real-World Evidence

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr 117)

DOI

10.1200/JCO.2023.41.6_suppl.117

Abstract #

117

Poster Bd #

E5

Abstract Disclosures

Similar Posters

First Author: George Slade Mellgard

First Author: Elisa María Fernández Pérez

First Author: Zakaria Chakrani

First Author: Orazio Caffo